Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies

Overview of attention for article published in Annals of Neurology, November 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog
twitter: 14 X users

patent: 6 patents
facebook: 1 Facebook page

Readers on

mendeley: 127 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

AbbVie snags another preclinical Parkinson's program with $17M Caraway pact

Fierce Biotech, 09 Jun 2021

Caraway Therapeutics wasn’t going to partner off its Parkinson’s program for a few more years, but AbbVie came along with an…

ALZFORUM | NETWORKING FOR A CURE

Alzforum, 01 Nov 2019

Krohn L, Öztürk TN, Vanderperre B, Ouled Amar Bencheikh B, Ruskey JA, Laurent SB, Spiegelman D, Postuma RB, Arnulf I, Hu MT…

Genetic, structural and functional evidence link TMEM175 to synucleinopathies

MyNeuroNews, 28 Oct 2019

Abstract Objective The TMEM175/GAK/DGKQ locus is the 3rd strongest risk locus in genome‐wide association studies (GWAS) of…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.